InpharmD™Advancing Major Depressive Disorder Treatment: Exxua™ (gepirone extended release) Approval and…InpharmD’s Monthly DI CornerNov 30, 2023Nov 30, 2023
InpharmD™Guidelines Updates for Opportunistic Infections in Adults with HIVInpharmD’s Monthly DI CornerNov 1, 2023Nov 1, 2023
InpharmD™Nirsevimab: A Promising Breakthrough in RSV PreventionInpharmD’s Monthly DI CornerSep 29, 2023Sep 29, 2023
InpharmD™Zuranolone: A Milestone in Postpartum Depression TreatmentWritten By InpharmD Drug Information Fellow, Muna SaidAug 30, 2023Aug 30, 2023
InpharmD™Exploring the Therapeutic Potential of Metformin in Cirrhotic Patients with Diabetes: Safety…Written By InpharmD Drug Information Pharmacist: Dena HomayouneihAug 29, 2023Aug 29, 2023
InpharmD™Meet the InpharmD 2022 Fellows — Dena HomayouniehTake a moment to get to know our current InpharmD fellows and what their experiences have been like so far!Nov 25, 2022Nov 25, 2022
InpharmD™Meet the InpharmD 2022 Fellows — Joy UgwuanyiTake a moment to get to know our current InpharmD fellows and what their experiences have been like so far!Nov 23, 2022Nov 23, 2022
InpharmD™Meet the InpharmD 2022 Fellows — Larissa A. MelnykTake a moment to get to know our current InpharmD fellows and what their experiences have been like so far!Nov 21, 2022Nov 21, 2022
InpharmD™SGLT2 Inhibitors — A New Solution for Heart Failure?Written by Dylan Brown, PharmD — Drug Information Specialist, InpharmDNov 11, 2022Nov 11, 2022
InpharmD™Yet Another Shortage? Alternatives to OxytocinInpharmD™ Clinical Literature Summaries — S4E2Oct 14, 2022Oct 14, 2022
